Emily covers emerging, leading edge technology in biomedicine, such as CRISPR, gene editing, gene therapy, synthetic biology, reproductive technology, neurotechnology (such as deep brain stimulation and brain-computer interfaces) and personalized medicine. She's interested in innovative technology stories that will be big trends several years in the future.

You can read her stories at https://www.technologyreview.com/profile/emily-mullin/ and about her at linkedin.com/in/emilymullin.